Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rosenzweig

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Current Hematologic Malignancy Reports|June 9, 2021
Amyloidosis with Cardiac Involvement: Identification, Characterization, and ManagementFaizi Jamal, Michael Rosenzweig
Journal of Hematology & Oncology|November 22, 2011
Light chain (AL) amyloidosis: update on diagnosis and managementMichael Rosenzweig, Heather Landau
Hematology/Oncology Clinics of North America|October 25, 2020
Liver and Gastrointestinal InvolvementMichael Rosenzweig, Raymond L Comenzo
Journal of Clinical Pharmacology|November 26, 2009
Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti-CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitusPawel Wiczling, Michael Rosenzweig, Louis Vaickus, et al.
Journal of Virological Methods|November 26, 2009
Development of a quantitative assay to measure EBV viral load in patients with autoimmune type 1 diabetes and healthy subjectsMichael Rosenzweig, Carol A Rosenthal, Valerie M Torres, et al.
Immunology|January 12, 2010
Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic miceDevangi S Mehta, Rudy A Christmas, Herman Waldmann, et al.
Frontiers in Immunology|August 21, 2024
Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administrationScott R Goldsmith, May San-Rozano, Justine Katindoy, et al.
Ejhaem|June 18, 2026
BCMA CAR T for AL Amyloidosis After Plasmacytic Relapse of Lymphoplasmacytic LymphomaNadia Al Haddad, Eugene Brailovski, Jacqueline Dela-Pena, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2007
A new transthyretin variant (Glu61Gly) associated with cardiomyopathyMichael Rosenzweig, Martha Skinner, Tatiana Prokaeva, et al.
Echocardiography (Mount Kisco, N.Y.)|March 25, 2026
Echocardiographic Markers of Cardiac Response to Therapy in Patients with Light Chain AmyloidosisDaniel Ng, Stephanie Wu, Huiyan Ma, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Current Hematologic Malignancy Reports|June 9, 2021
Amyloidosis with Cardiac Involvement: Identification, Characterization, and ManagementFaizi Jamal, Michael Rosenzweig
Journal of Hematology & Oncology|November 22, 2011
Light chain (AL) amyloidosis: update on diagnosis and managementMichael Rosenzweig, Heather Landau
Hematology/Oncology Clinics of North America|October 25, 2020
Liver and Gastrointestinal InvolvementMichael Rosenzweig, Raymond L Comenzo
Journal of Clinical Pharmacology|November 26, 2009
Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti-CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitusPawel Wiczling, Michael Rosenzweig, Louis Vaickus, et al.
Journal of Virological Methods|November 26, 2009
Development of a quantitative assay to measure EBV viral load in patients with autoimmune type 1 diabetes and healthy subjectsMichael Rosenzweig, Carol A Rosenthal, Valerie M Torres, et al.
Immunology|January 12, 2010
Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic miceDevangi S Mehta, Rudy A Christmas, Herman Waldmann, et al.
Frontiers in Immunology|August 21, 2024
Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administrationScott R Goldsmith, May San-Rozano, Justine Katindoy, et al.
Ejhaem|June 18, 2026
BCMA CAR T for AL Amyloidosis After Plasmacytic Relapse of Lymphoplasmacytic LymphomaNadia Al Haddad, Eugene Brailovski, Jacqueline Dela-Pena, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2007
A new transthyretin variant (Glu61Gly) associated with cardiomyopathyMichael Rosenzweig, Martha Skinner, Tatiana Prokaeva, et al.
Echocardiography (Mount Kisco, N.Y.)|March 25, 2026
Echocardiographic Markers of Cardiac Response to Therapy in Patients with Light Chain AmyloidosisDaniel Ng, Stephanie Wu, Huiyan Ma, et al.
Pageof 5